Does Trazodone Help with Sleep?
Trazodone, an antidepressant, is commonly prescribed off-label at low doses (25-100 mg) for insomnia because it causes sedation through histamine and alpha-1 receptor blockade, unlike its main serotonin reuptake inhibition at higher antidepressant doses.[1] Studies show it reduces sleep latency (time to fall asleep) by 10-30 minutes and increases total sleep time by 30-60 minutes in people with primary insomnia or depression-related sleep issues, with response rates around 60-80% in short-term trials (2-4 weeks).[2][3] It's not FDA-approved for insomnia but ranks among the top U.S. sleep medications due to low cost, generic availability, and milder effects compared to benzodiazepines.
How Does Trazodone Work for Insomnia?
It blocks serotonin reuptake weakly at low doses but primarily sedates via H1 antagonism (like antihistamines) and 5-HT2A receptor blockade, promoting non-REM sleep without much REM suppression. Effects peak 1-2 hours after dosing, lasting 6-8 hours, making it suitable for sleep onset but less ideal for middle-of-night waking.[1][4]
Compared to Other Sleep Aids
Trazodone outperforms placebo in meta-analyses but shows similar efficacy to zolpidem or doxepin for sleep maintenance, with lower abuse potential (no gamma-aminobutyric acid effects).[3] Unlike melatonin (natural regulator) or ramelteon (melatonin agonist), it carries more next-day drowsiness risk. Benzodiazepines like lorazepam provide faster relief but higher dependence risk; trazodone is preferred for long-term use in depression patients.[2][5]
| Medication | Primary Mechanism | Typical Dose for Sleep | Dependence Risk | Next-Day Impairment |
|------------|-------------------|-----------------------|-----------------|---------------------|
| Trazodone | H1/5-HT2A blockade | 25-100 mg | Low | Moderate |
| Zolpidem | GABA agonist | 5-10 mg | Moderate | Low-Moderate |
| Doxepin | H1 blockade | 3-6 mg | Low | Low |
| Melatonin | MT1/MT2 agonist | 1-5 mg | None | None |
Common Side Effects and Risks
Drowsiness (24%), dry mouth (15%), dizziness (10%), and orthostatic hypotension occur frequently, especially in older adults.[1] Priapism (rare, <1%) requires emergency care. Avoid with MAOIs or strong CYP3A4 inhibitors like ketoconazole due to serotonin syndrome risk. Tolerance can develop after 4-6 weeks, reducing efficacy.[4][6] Not recommended in pregnancy (Category C) or for children under 18.
Who Benefits Most and When to Avoid It
Best for insomnia tied to depression, anxiety, or SSRIs; less effective for primary insomnia without psychiatric issues.[2] Elderly patients face higher fall risk (odds ratio 1.5-2.0).[6] Alternatives include CBT-I (first-line, 70-80% efficacy without drugs) or low-dose doxepin if trazodone fails.[5]
Dosage, Timing, and Withdrawal
Start at 25-50 mg 30-60 minutes before bed; titrate up if needed. No abrupt stop needed at low doses—taper over 1-2 weeks to avoid rebound insomnia or anxiety.[1][4] Generic pricing: $4-10/month (GoodRx average).
[1] FDA Label: Trazodone Hydrochloride
[2] JAMA Internal Medicine: Trazodone for Insomnia (2018 Meta-Analysis)
[3] Sleep Medicine Reviews: Off-Label Insomnia Treatments (2020)
[4] American Academy of Sleep Medicine Guidelines
[5] Cochrane Review: Antidepressants for Insomnia
[6] UpToDate: Trazodone in Sleep Disorders